Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan

INTRODUCTION: Kras mutation is the most common driver oncogene present in patients with NSCLC. Recently, the precision medicine for patients with Kras-mutated NSCLC has been under investigation, but the best treatment is still unknown. This study aimed to analyze the clinical characteristics, immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shang-Gin, Liao, Wei-Yu, Su, Kang-Yi, Yu, Sung-Liang, Huang, Yen-Lin, Yu, Chong-Jen, Chih-Hsin Yang, James, Shih, Jin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474407/
https://www.ncbi.nlm.nih.gov/pubmed/34589991
http://dx.doi.org/10.1016/j.jtocrr.2020.100140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474407/
https://www.ncbi.nlm.nih.gov/pubmed/34589991
http://dx.doi.org/10.1016/j.jtocrr.2020.100140

Ejemplares similares